Literature DB >> 26524988

The Impacts of China's Urban Employee Basic Medical Insurance on Healthcare Expenditures and Health Outcomes.

Feng Huang1,2, Li Gan3.   

Abstract

At the end of 1998, China launched a government-run mandatory insurance program, the urban employee basic medical insurance (UEBMI), to replace the previous medical insurance system. Using the UEBMI reform in China as a natural experiment, this study identifies variations in patient cost sharing that were imposed by the UEBMI reform and examines their effects on the demand for healthcare services. Using data from the 1991-2006 waves of the China Health and Nutrition Survey, we find that increased cost sharing is associated with decreased outpatient medical care utilization and expenditures but not with decreased inpatient care utilization and expenditures. Patients from low-income and middle-income households or with less severe medical conditions are more sensitive to prices. We observe little impact on patient's health, as measured by self-reported health status.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cost-sharing; health expenditure; health insurance; urban China

Mesh:

Year:  2015        PMID: 26524988     DOI: 10.1002/hec.3281

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  13 in total

1.  What Are the Determinants of the Decision to Purchase Private Health Insurance in China?

Authors:  Guangsheng Wan; Zixuan Peng; Yufeng Shi; Peter C Coyte
Journal:  Int J Environ Res Public Health       Date:  2020-07-24       Impact factor: 3.390

2.  Multi-Level Social Health Insurance System in the Age of Frequent Employment Change: The Urban Unemployment-Induced Insurance Transition and Healthcare Utilization in China.

Authors:  Bocong Yuan; Jiannan Li; Lily Wu; Zhaoguo Wang
Journal:  Healthcare (Basel)       Date:  2019-06-13

3.  Understanding Healthcare Utilization In China Through The Andersen Behavioral Model: Review Of Evidence From The China Health And Nutrition Survey.

Authors:  Shu Zhang; Qihui Chen; Bo Zhang
Journal:  Risk Manag Healthc Policy       Date:  2019-11-11

4.  Impacts of government supervision on hospitalization costs for inpatients with COPD: An interrupted time series study.

Authors:  Peiyi Li; Zhanqi Duan; Ziwu Zhang; Yunzhen He; Weimin Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

5.  Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China.

Authors:  Wen He
Journal:  Eur J Health Econ       Date:  2021-07-05

6.  Social health insurance, healthcare utilization, and costs in middle-aged and elderly community-dwelling adults in China.

Authors:  Zhonghua Wang; Xiangjun Li; Mingsheng Chen; Lei Si
Journal:  Int J Equity Health       Date:  2018-02-02

7.  Healthcare Supply Chain Network Coordination Through Medical Insurance Strategies with Reference Price Effect.

Authors:  Lingyu Gao; Xiaoli Wang
Journal:  Int J Environ Res Public Health       Date:  2019-09-18       Impact factor: 3.390

8.  Associations Between Schemes of Social Insurance and Self-Rated Health Comparison: Evidence From the Employed Migrants in Urban China.

Authors:  Ming Guan
Journal:  Front Public Health       Date:  2019-09-18

9.  The impact of user charges on health outcomes in low-income and middle-income countries: a systematic review.

Authors:  Vicky Mengqi Qin; Thomas Hone; Christopher Millett; Rodrigo Moreno-Serra; Barbara McPake; Rifat Atun; John Tayu Lee
Journal:  BMJ Glob Health       Date:  2019-01-10

10.  Catastrophic health expenditure incidence and its equity in China: a study on the initial implementation of the medical insurance integration system.

Authors:  Huan Liu; Hong Zhu; Jiahui Wang; Xinye Qi; Miaomiao Zhao; Linghan Shan; Lijun Gao; Zheng Kang; Mingli Jiao; Lin Pan; Ruohui Chen; Baohua Liu; Qunhong Wu; Ning Ning
Journal:  BMC Public Health       Date:  2019-12-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.